Levent CANSEVER, Ümit AYDOĞMUŞ, Adalet DEMİR, Seyit İbrahim DİNÇER, Celalettin İbrahim KOCATÜRK, Yaşar SÖNMEZOĞLU, Mehmet Zeki GÜNLÜOĞL, Mehmet Ali BEDİRHAN

Prognostic significance of tumor extension to the main bronchus in the patients with resected right upper lobe lung cancer

Amaç: Küçük hücreli dışı akciğer kanseri (KHDAK) bulunan hastalarda sağ üst lob tümörlerinin ana bronşa yayılımın prognostik önemi araştırıldı.Çalışma planı: 1998-2007 yılları arasında sağ üst lob KHDAK ameliyatı uygulanan 302 hastanın sonuçları geriye dönük olarak incelendi. pT2 veya pT3 tümörü tamamen çıkarılmış olan ve lenf nodu yayılımı bulunmayan 169 hasta analiz edildi. Hastalar üç gruba ayrıldı; pT2 (n=82), pT3 olup ana bronş invazyonu o lanlar (pT3-MB; n=41), ana bronş invazyonu bulunmayan pT3 olgular (n=46).Bulgular: Beş yıllık sağkalım oranları pT3-MB'li hastalar için %36.7, pT2'li hastalar için %55.1 ve pT3 tümörlü hastalar için %50.7 (p=0.28) idi. Sağkalım pnömonektomi uygulanan hastalarda diğerlerine göre daha kötü idi (p

Sağ üst lob akciğer kanserli rezeksiyon uygulanmış hastalarda tümörün ana bronşa yayılımının prognostik önemi

Background: We evaluated the prognostic role of main bronchial extension of right upper lobe tumors in patients with non-small cell lung cancer (NSCLC).Methods: Between 1998 and 2007, the results of surgery in 302 patients with right upper lobe NSCLC were investigated retrospectively. One-hundred-sixty-nine patients with completely resected pT2 o r p T3 tumor without lymph node metastasis were analyzed. The patients were divided into three groups; patients with NSCLC staged as pT2 (n=82), pT3 with invasion of the main bronchus (pT3-MB; n=41), and pT3 patients without main bronchial involvement (n=46).Results: The five-year survival rate of patients with pT3-MB was 36.7%, whereas it was 55.1% for patients with pT2 and 50.7% for patients with other pT3 tumor (p=0.28). Survival of the patients who had undergone pneumonectomy was poorer than that of others (p

PDF

___

1) Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
2) Shields TW. Surgical anatomy of the lungs. In: Shields TW, LoCicero J, Ponn RB, editors. General thoracic surgery. Vol.1. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 59-73.
3) Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, Sobin LH. Histological typing of lung and pleural tumours (WHO. World Health Organization. International Histological Classification of Tumours). 3rd ed. New York. Springer-Verlag; 1999.
4) Riquet M, Lang-Lazdunski L, Le PB, Dujon A, Souilamas R, Danel C, et al. Characteristics and prognosis of resected T3 non-small cell lung cancer. Ann Thorac Surg 2002; 73:253-8.
5) Pitz CC, Brutel de la Rivière A, Elbers HR, Westermann CJ, van den Bosch JM. Results of resection of T3 non-small cell lung cancer invading the mediastinum or main bronchus. Ann Thorac Surg 1996;62:1016-20.
6) Ilhan M, Demir A, Akin H, Gunluoglu M, Olçmen A, Dncer SI. Characteristics and prognosis of resected T3 non-small cell lung cancer. Minerva Chir 2008;63:101-8.
7) Demir A, Gunluoglu MZ, Kara HV, Buyukpinarbasili N, Dincer SI. Prognostic factors in resected T3 non-small cell lung carcinoma: perineural invasion as a new prognostic factor. Thorac Cardiovasc Surg 2008;56:93-8.
8) Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H. How should interlobar pleural invasion be classified? Prognosis of resected T3 non-small cell lung cancer. Ann Thorac Surg 1999;68:2049-52.
9) Riquet M, Manac'h D, Le Pimpec-Barthes F, Dujon A, Chehab A. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg 1999;67:1572-6.
10) Yano T, Yokoyama H, Inoue T, Asoh H, Tayama K, Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg 1994;107:1398-402.
11) Khan OA, Fitzgerald JJ, Field ML, Soomro I, Beggs FD, Morgan WE, et al. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung. Ann Thorac Surg 2004;77:1173-8.
12) Deslauriers J, Grégoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences. Ann Thorac Surg 2004;77:1152-6.
13) Watanabe S, Asamura H, Suzuki K, Tsuchiya R. Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg 2004;78:999-1002.
14) Ma Z, Dong A, Fan J, Cheng H. Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A meta-analysis. Eur J Cardiothorac Surg 2007;32:20-8.